“…Serum or plasma concentrations of cTnI have been reported in cats and dogs that are either healthy or with various diseases, including gastric dilation and volvulus [4], congestive heart failure [5], heatstroke [6], cardiomyopathy, and pericardial disease [7][8][9], and dogs receiving chemotherapy [10]. Circulating cTnI concentrations have been evaluated in healthy horses [11], Thoroughbreds in training or on pasture [12], horses undergoing endurance events [13] or treadmill exercise [14], and horses with various diseases, including myocarditis [15], cantharidin toxicosis [16], ruptured aortic jet lesions [17], airway obstruction [18], babesiosis [19], electrical cardioconversion [20,21], sepsis [22] and monensin intoxication [23]. Preferred times to test blood for cTnI levels following athletic performance or other events that may cause acute myocardial injury are not yet established and would be affected by time of release from the myocytes, location of release within the myocytes, duration of release and elimination half-life (T1/2) of cTnI in the horse.…”